JUL 04, 2018 2:11 AM PDT

First Drug Approved for The Treatment of Hyperhidrosis

WRITTEN BY: Nouran Amin

Hyperhidrosis is a chronic skin condition that results in the increased production of sweat than needed. A certain amount of sweat is normally produced to regulate body temperature, an excess of sweat becomes unnecessary.

Now, the U.S. Food and Drug Administration (FDA) has approved the first drug developed to reduce excessive sweating. The drug will particularly be effective in one type of hyperhidrosis caused under the armpit, better known as primary axillary hyperhidrosis.

According to the drug manufacturing California-based pharmaceutical company, Dermira Inc, the drug which is now known as Qbrexza and will be available in pharmacies in October 2018.

Affected individuals prescribed Qbrexza will receive it as a drug packed inside a cloth. They will be able to use it to wipe over their skin every day to block the sweat glands from activating and thus no sweat will be released from the treated area.

Roughly 15 million Americans experience some form of excessive sweating, with more than 10 million individuals experiencing excessive underarm perspiration.

Excessive sweating is often associated with social embarrassment and emotional burdens to affected individuals. Such distress due to this skin condition has inspired dermatologists to seek effective treatment options.

“From the start, our goal was to develop an approach that went beyond masking a person’s excessive underarm sweating and instead focused on treating the condition in a clinically meaningful way," says Derira Chairman Tom Wiggans.

The FDA approval of Qbrexza was based on two clinical trials.

Most frequent noted side effects of Qbrexza include dry mouth, dilated pupils, sore throat, headache, urinary hesitation, blurred vision, dry nose, dry eyes, dry skin and constipation.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 11, 2019
Neuroscience
NOV 11, 2019
The Women Who Can Smell Without Olfactory Bulbs
Until now, it has been commonly accepted that our sense of smell depends on the transmission of olfactory information from the nose to the olfactory bulb i...
NOV 13, 2019
Drug Discovery & Development
NOV 13, 2019
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
DEC 16, 2019
Drug Discovery & Development
DEC 16, 2019
IV Treatment for Traumatic Brain Injury
Scientists are now using exosomes intravenously as a method of cell-to-cell technology for treating patients with traumatic brain injury (TBI). They discov...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
JAN 14, 2020
Cancer
JAN 14, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
JAN 21, 2020
Cannabis Sciences
JAN 21, 2020
Medical Marijuana Ineffective for Long Term Pain Management
Medicinal cannabis may not as effective as once thought as a solution for sleep problems for those with chronic pain in the long run, according to new find...
Loading Comments...